(Q27852366)

English

A clinically relevant androgen receptor mutation confers resistance to second-generation antiandrogens enzalutamide and ARN-509.

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

A clinically relevant androgen receptor mutation confers resistance to second-generation antiandrogens enzalutamide and ARN-509. (English)
James D Joseph
0 references
Nhin Lu
0 references
Jing Qian
0 references
John Sensintaffar
0 references
Gang Shao
0 references
Dan Brigham
0 references
Michael Moon
0 references
Edna Chow Maneval
0 references
Isan Chen
0 references
Beatrice Darimont
0 references
Jeffrey H Hager
0 references
September 2013
0 references
3
0 references
9
0 references
1020-9
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit